News

• Latest News
• October 2022
• April 2022
• March 2022
• February 2022
• July 2021
• April 2021
• May 2020
• January 2020
• October 2019
• May 2019
• March 2019
• February 2019
• January 2019
• November 2018
• July 2018
• December 2017
• November 2017
• August 2017
• May 2017
• November 2016
• October 2016
• March 2016
• February 2016
• April 2015
• September 2014
• June 2014
• March 2014
• November 2013
• May 2013
• All News A–Z

News: November 2017

Exploring the economics of sight-saving technology

Over two million people in the UK are living with sight loss. This will double to nearly four million people by 2050 as the population ages and underlying causes like obesity and diabetes increase. This places huge pressure on NHS eye care services. The 2016 Royal National Institute for the Blind (RNIB) report highlighted that sight loss is estimated to cost over £28 billion to the UK economy. Research into new sight-saving technology could improve the lives of people at risk of sight loss and provide saving to the NHS and wider economy. Two researchers from Centre for Health Economics and Medicines Evaluation CHEME, are co-investigators on the optical coherence tomography (OCT) study, which has been awarded £1.3 million of funding from the National Institute for Health Research (NIHR) Invention for Innovation (i4i) Programme.

Publication date: 23 November 2017

Poster award for CHEME at International Society for Pharmaco Economic and Outcomes Research (ISPOR) conference

Members of the pharmacoeconomics and medicines evaluation section of the Centre for Health Economics and Medicines Evaluation (CHEME) attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress at Glasgow on the 6 th -8 th November.

Publication date: 15 November 2017